Gala Pharmaceutical, Inc. announced notable progress toward opening its doors and serving its rapidly growing market. The Company’s application to operate a TYPE 8 Medical Cannabis Testing Lab has been deemed complete by the City of Long Beach and, through its subsidiary, Gala Pharmaceutical California, Inc., has filed for its California state license. In addition, Gala has submitted the application for its building permit. The Company believes that California’s stringent cannabis testing regulations, which have rolled out in phases throughout 2018 via the Bureau of Cannabis Control, have created a highly favorable business environment in which to establish and expand its services. Cannabis testing laboratories are responsible for ensuring safety and consistency in the recreational and medicinal cannabis available to consumers and patients. Labs test for analysis of potency, residual pesticides, heavy metals, microbial contamination, residual solvents, moisture content, and foreign contaminants. Industry experts say the current bottleneck in the cannabis industry is caused by the lack of sufficient facilities to keep up with demand for testing.